skip to main content
Idioma:
Primo Advanced Search
Primo Advanced Search Query Term
Primo Advanced Search Query Term
Primo Advanced Search Query Term
Primo Advanced Search prefilters
Busca Simples
Resultados 1 2 3 4 next page
Refinado por: Nome da Publicação: Journal Of Clinical Oncology remover
Result Number Material Type Add to My Shelf Action Record Details and Options
1
CSF concentration of the anaplastic lymphoma kinase inhibitor crizotinib
CSF concentration of the anaplastic lymphoma kinase inhibitor crizotinib
Material Type:
Artigo 		Adicionar ao Meu Espaço

CSF concentration of the anaplastic lymphoma kinase inhibitor crizotinib

Costa, Daniel B ; Kobayashi, Susumu ; Pandya, Shuchi S ; Yeo, Wee-Lee ; Shen, Zhongzhou ; Tan, Weiwei ; Wilner, Keith D

Journal of clinical oncology, 2011-05, Vol.29 (15), p.e443-e445 [Periódico revisado por pares]

United States

Texto completo disponível

Citações Citado por
2
Clinical Features and Outcome of Patients With Non–Small-Cell Lung Cancer Who Harbor EML4-ALK
Clinical Features and Outcome of Patients With Non–Small-Cell Lung Cancer Who Harbor EML4-ALK
Material Type:
Artigo 		Adicionar ao Meu Espaço

Clinical Features and Outcome of Patients With Non–Small-Cell Lung Cancer Who Harbor EML4-ALK

SHAW, Alice T ; YEAP, Beow Y ; SETTLEMAN, Jeffrey ; KOBAYASHI, Susumu ; MARK, Eugene J ; RODIG, Scott J ; CHIRIEAC, Lucian R ; KWAK, Eunice L ; LYNCH, Thomas ; IAFRATE, A. John ; MINO-KENUDSON, Mari ; DIGUMARTHY, Subba R ; COSTA, Daniel B ; HEIST, Rebecca S ; SOLOMON, Benjamin ; STUBBS, Hannah ; ADMANE, Sonal ; MCDERMOTT, Ultan

Journal of clinical oncology, 2009-09, Vol.27 (26), p.4247-4253 [Periódico revisado por pares]

Alexandria, VA: American Society of Clinical Oncology

Texto completo disponível

Citações Citado por
3
Randomized Phase II Study of Erlotinib Plus Tivantinib Versus Erlotinib Plus Placebo in Previously Treated Non–Small-Cell Lung Cancer
Randomized Phase II Study of Erlotinib Plus Tivantinib Versus Erlotinib Plus Placebo in Previously Treated Non–Small-Cell Lung Cancer
Material Type:
Artigo 		Adicionar ao Meu Espaço

Randomized Phase II Study of Erlotinib Plus Tivantinib Versus Erlotinib Plus Placebo in Previously Treated Non–Small-Cell Lung Cancer

SEQUIST, Lecia V ; VON PAWEL, Joachim ; RAMLAU, Rodryg ; ARTHUR, Susan ; GORBACHEVSKY, Igor ; SCHWARTZ, Brian ; SCHILLER, Joan H ; GARMEY, Edward G ; AKERLEY, Wallace L ; BRUGGER, Wolfram ; FERRARI, Dora ; YINPU CHEN ; COSTA, Daniel B ; GERBER, David E ; ORLOV, Sergey

Journal of clinical oncology, 2011-08, Vol.29 (24), p.3307-3315 [Periódico revisado por pares]

Alexandria, VA: American Society of Clinical Oncology

Texto completo disponível

Citações Citado por
4
From Hope to Reality: Durable Overall Survival With Immune Checkpoint Inhibitors for Advanced Lung Cancer
From Hope to Reality: Durable Overall Survival With Immune Checkpoint Inhibitors for Advanced Lung Cancer
Material Type:
Artigo 		Adicionar ao Meu Espaço

From Hope to Reality: Durable Overall Survival With Immune Checkpoint Inhibitors for Advanced Lung Cancer

Rangachari, Deepa ; Costa, Daniel B

Journal of clinical oncology, 2019-10, Vol.37 (28), p.2511-2513 [Periódico revisado por pares]

United States: American Society of Clinical Oncology

Texto completo disponível

Citações Citado por
5
Clinical Experience With Crizotinib in Patients With Advanced ALK-Rearranged Non-Small-Cell Lung Cancer and Brain Metastases
Clinical Experience With Crizotinib in Patients With Advanced ALK-Rearranged Non-Small-Cell Lung Cancer and Brain Metastases
Material Type:
Artigo 		Adicionar ao Meu Espaço

Clinical Experience With Crizotinib in Patients With Advanced ALK-Rearranged Non-Small-Cell Lung Cancer and Brain Metastases

Costa, Daniel B ; Shaw, Alice T ; Ou, Sai-Hong I ; Solomon, Benjamin J ; Riely, Gregory J ; Ahn, Myung-Ju ; Zhou, Caicun ; Shreeve, S Martin ; Selaru, Paulina ; Polli, Anna ; Schnell, Patrick ; Wilner, Keith D ; Wiltshire, Robin ; Camidge, D Ross ; Crinò, Lucio

Journal of clinical oncology, 2015-06, Vol.33 (17), p.1881-1888 [Periódico revisado por pares]

United States: American Society of Clinical Oncology

Texto completo disponível

Citações Citado por
6
Intracranial Efficacy of Crizotinib Versus Chemotherapy in Patients With Advanced ALK-Positive Non-Small-Cell Lung Cancer: Results From PROFILE 1014
Intracranial Efficacy of Crizotinib Versus Chemotherapy in Patients With Advanced ALK-Positive Non-Small-Cell Lung Cancer: Results From PROFILE 1014
Material Type:
Artigo 		Adicionar ao Meu Espaço

Intracranial Efficacy of Crizotinib Versus Chemotherapy in Patients With Advanced ALK-Positive Non-Small-Cell Lung Cancer: Results From PROFILE 1014

Solomon, Benjamin J ; Cappuzzo, Federico ; Felip, Enriqueta ; Blackhall, Fiona H ; Costa, Daniel B ; Kim, Dong-Wan ; Nakagawa, Kazuhiko ; Wu, Yi-Long ; Mekhail, Tarek ; Paolini, Jolanda ; Tursi, Jennifer ; Usari, Tiziana ; Wilner, Keith D ; Selaru, Paulina ; Mok, Tony S K

Journal of clinical oncology, 2016-08, Vol.34 (24), p.2858-2865 [Periódico revisado por pares]

United States

Texto completo disponível

Citações Citado por
7
SELECT: A Phase II Trial of Adjuvant Erlotinib in Patients With Resected Epidermal Growth Factor Receptor-Mutant Non-Small-Cell Lung Cancer
SELECT: A Phase II Trial of Adjuvant Erlotinib in Patients With Resected Epidermal Growth Factor Receptor-Mutant Non-Small-Cell Lung Cancer
Material Type:
Artigo 		Adicionar ao Meu Espaço

SELECT: A Phase II Trial of Adjuvant Erlotinib in Patients With Resected Epidermal Growth Factor Receptor-Mutant Non-Small-Cell Lung Cancer

Pennell, Nathan A ; Neal, Joel W ; Chaft, Jamie E ; Azzoli, Christopher G ; Jänne, Pasi A ; Govindan, Ramaswamy ; Evans, Tracey L ; Costa, Daniel B ; Wakelee, Heather A ; Heist, Rebecca S ; Shapiro, Marc A ; Muzikansky, Alona ; Murthy, Sudish ; Lanuti, Michael ; Rusch, Valerie W ; Kris, Mark G ; Sequist, Lecia V

Journal of clinical oncology, 2019-01, Vol.37 (2), p.97-104 [Periódico revisado por pares]

United States: American Society of Clinical Oncology

Texto completo disponível

Citações Citado por
8
Identification of somatic genomic alterations in circulating tumors cells: another step forward in non-small-cell lung cancer?
Identification of somatic genomic alterations in circulating tumors cells: another step forward in non-small-cell lung cancer?
Material Type:
Artigo 		Adicionar ao Meu Espaço

Identification of somatic genomic alterations in circulating tumors cells: another step forward in non-small-cell lung cancer?

Costa, Daniel B

Journal of clinical oncology, 2013-06, Vol.31 (18), p.2236-2239 [Periódico revisado por pares]

United States

Texto completo disponível

Citações Citado por
9
Differential responses to erlotinib in epidermal growth factor receptor (EGFR)-mutated lung cancers with acquired resistance to gefitinib carrying the L747S or T790M secondary mutations
Differential responses to erlotinib in epidermal growth factor receptor (EGFR)-mutated lung cancers with acquired resistance to gefitinib carrying the L747S or T790M secondary mutations
Material Type:
Artigo 		Adicionar ao Meu Espaço

Differential responses to erlotinib in epidermal growth factor receptor (EGFR)-mutated lung cancers with acquired resistance to gefitinib carrying the L747S or T790M secondary mutations

Costa, Daniel B ; Schumer, Susan T ; Tenen, Daniel G ; Kobayashi, Susumu

Journal of clinical oncology, 2008-03, Vol.26 (7), p.1182-1184 [Periódico revisado por pares]

United States

Texto completo disponível

Citações Citado por
10
More Than Just an Oncogene Translocation and a Kinase Inhibitor: Kevin's Story
More Than Just an Oncogene Translocation and a Kinase Inhibitor: Kevin's Story
Material Type:
Artigo 		Adicionar ao Meu Espaço

More Than Just an Oncogene Translocation and a Kinase Inhibitor: Kevin's Story

COSTA, Daniel B

Journal of clinical oncology, 2012, Vol.30 (1), p.110-112 [Periódico revisado por pares]

Alexandria, VA: American Society of Clinical Oncology

Texto completo disponível

Citações Citado por
Resultados 1 2 3 4 next page

Personalize Seus Resultados

  1. Editar

Refine Search Results

Expandir Meus Resultados

  1.   

  • Realização: ABCD-USP USP   Logos de Redes Sociais: Freepik

Buscando em bases de dados remotas. Favor aguardar.